Rznomics
Search results
Scope
Date
~
-
Bio & PharmaSouth Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
10 HOURS AGO
1
Latest News
- 1 S.Korea’s Naver to launch Silicon Valley venture arm in aggressive AI push
- 2 UK chip testing device maker TeraView seeks Kosdaq debut
- 3 K-Beauty defies seasonal slump with record $980 mn in April exports
- 4 Samsung flexes financial muscle as insurance, card units top sector rankings
- 5 Greystar hires ex-Samsung SRA manager to launch Seoul office
